Technology transfer to developing country vaccine manufacturers to improve global influenza vaccine production: A success story and a window into the future

被引：1
作者：
LaForce, F. Marc [1 ]
机构：
[1] PATH, Washington, DC 20001 USA
来源：
VACCINE | 2011年 / 29卷
关键词：
D O I：
10.1016/j.vaccine.2011.02.077
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：A1 / A1
页数：1
相关论文
共 5 条
[1]  
Garg SP, 2009, INDIAN PEDIATR, V46, P736
[2]  
*INT VACC I, 2009, OR CHOL VACC
[3]   Emerging markets & emerging needs: Developing countries vaccine manufacturers' perspective & its current status [J].
Jadhav, Suresh S. ;
Gautam, Manish ;
Gairola, Sunil .
BIOLOGICALS, 2009, 37 (03) :165-168
[4]   The meningitis vaccine project [J].
LaForce, F. Marc ;
Konde, Kader ;
Viviani, Simonetta ;
Preziosi, Marie-Pierre .
VACCINE, 2007, 25 :A97-A100
[5]   The role of emerging manufacturers in access to innovative vaccines of public health importance [J].
Milstien, Julie B. ;
Kaddar, Miloud .
VACCINE, 2010, 28 (09) :2115-2121
1